Emily Simonoff is Professor of Child and Adolescent Psychiatry in the Child and Adolescent Mental Health Services (CAMHS) Neuropsychiatry Service, head of the Child and Adolescent Psychiatry department at the Institute of Psychiatry and lead for the CAMHS Clinical Academic Group at King's Health Partners, King's College London. [1] [2]
Simonoff is chair of the Mental Health Research Network for treatment of children with mental health problems and a member of the NICE guideline development group for treatment and diagnosis of autism in children and adolescents. She is on the editorial board of British Journal of Psychiatry. [1]
She is a Fellow of the Royal College of Psychiatrists [3] and a Senior Investigator at the National Institute for Health and Care Research (NIHR). [4]
In February 2025, the National Institute for Health and Care Research (NIHR) revealed that the NHS had commissioned Emily Simonoff to lead a £10.7 million clinical trial on puberty blockers which is planned to last until 2031. [5] [6]